Timolol and Abilify drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Timolol (timolol) and Abilify (aripiprazole). Common drug interactions include dyspnoea among females and parkinson's disease among males.

The phase IV clinical study analyzes what interactions people have when they take Timolol and Abilify. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Timolol?

Timolol has active ingredients of timolol. It is often used in glaucoma. eHealthMe is studying from 9,142 Timolol users. Check the latest studies of Timolol.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,455 Abilify users. Check the latest studies of Abilify.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 16, 2026

16 people who take Timolol and Abilify together, and have interactions are studied.

Timolol and Abilify drug interactions.

What are the common drug interactions of Timolol and Abilify, by gender? *:

female:

  1. Dyspnoea (difficult or laboured respiration)
  2. Heart rate increased
  3. Hunger
  4. Insomnia (sleeplessness)
  5. Obsessive-compulsive disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;)
  6. Periodic limb movement disorder
  7. Sleep paralysis (waking up and unable to move or speak)
  8. Snoring
  9. Weight increased
  10. Contusion (a type of hematoma of tissue in which capillaries)

male:

  1. Parkinson's disease
  2. Agitation (state of anxiety or nervous excitement)
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
  5. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  6. Atrioventricular block (heart block)
  7. Blood pressure increased
  8. Coma (state of unconsciousness lasting more than six hours)
  9. Death
  10. Fall

What are the common drug interactions of Timolol and Abilify, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)

50-59:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Contusion (a type of hematoma of tissue in which capillaries)
  4. Crying
  5. Disturbance in attention
  6. Dyspnoea (difficult or laboured respiration)
  7. Dysuria (painful or difficult urination)
  8. Fatigue (feeling of tiredness)
  9. Heart rate increased
  10. Hunger

60+:

  1. Chronic kidney disease
  2. Dizziness
  3. Fatigue (feeling of tiredness)
  4. Hepatitis b
  5. Hyperkalaemia (damage to or disease of the kidney)
  6. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  7. Hypokalaemia (low potassium)
  8. Hypothermia (body temperature drops below the required temperature for normal metabolism and body functions)
  9. Nephrogenic anaemia (anaemia due to kidney disease)
  10. Perioral dermatitis (facial rash that causes bumps to develop around the mouth)

What are the existing conditions these people have? *

  1. Sleep Disorder: 5 people, 31.25%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 18.75%
  3. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 18.75%
  4. Stress And Anxiety: 3 people, 18.75%
  5. Insomnia (sleeplessness): 3 people, 18.75%
  6. Pain: 3 people, 18.75%
  7. Tremor (trembling or shaking movements in one or more parts of your body): 2 people, 12.50%
  8. Diabetes: 2 people, 12.50%
  9. Hypertriglyceridaemia (excess of triglycerides in the blood): 2 people, 12.50%
  10. High Blood Cholesterol: 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Timolol and Abilify?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Timolol and Abilify:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Timolol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Abilify:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Timolol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Abilify and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on timolol and aripiprazole (the active ingredients of Timolol and Abilify, respectively), and Timolol and Abilify (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: